113 related articles for article (PubMed ID: 1590269)
1. Chemotherapy of cervix cancer with mitolactol (dibromodulcitol, NSC 104800) and cisplatin. A phase I study of the Gynecologic Oncology Group.
Omura GA; Hubbard JL; Hatch KD; Schlaerth JB; Blessing JA
Am J Clin Oncol; 1992 Jun; 15(3):185-7. PubMed ID: 1590269
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
[TBL] [Abstract][Full Text] [Related]
3. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Stehman FB; Blessing JA; McGehee R; Barrett RJ
J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of cervix cancer with doxorubicin and cisplatin. A phase I pilot study of the Gynecologic Oncology Group.
Omura GA; Hubbard J; Hatch K
Am J Clin Oncol; 1985 Oct; 8(5):347-9. PubMed ID: 4061371
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
Gentile PS; Epremian BE; Seeger J; Hamm JT; Sheth SP
Am J Clin Oncol; 1988 Dec; 11(6):666-8. PubMed ID: 2461074
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
8. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
Kredentser DC
Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
10. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer.
Craighead PS; Pearcey R; Stuart G
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):791-5. PubMed ID: 11020576
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
12. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Bonomi P; Blessing J; Ball H; Hanjani P; DiSaia PJ
Gynecol Oncol; 1989 Sep; 34(3):357-9. PubMed ID: 2767528
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma.
Adachi S; Ogasawara T; Wakimoto E; Tsuji Y; Takemura T; Koyama K; Takayasu Y; Inoue J; Nakao N
Cancer; 2001 Jan; 91(1):74-9. PubMed ID: 11148562
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposure.
Ingle JN; Pfeifle DM; Green SJ; Kvols LK; Brunk SF; Reuter NF; Krook JE; Laurie JA; Everson LK; Marschke RF
Am J Clin Oncol; 1985 Aug; 8(4):275-82. PubMed ID: 3909798
[TBL] [Abstract][Full Text] [Related]
15. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Moore DH; Blessing JA; McQuellon RP; Thaler HT; Cella D; Benda J; Miller DS; Olt G; King S; Boggess JF; Rocereto TF
J Clin Oncol; 2004 Aug; 22(15):3113-9. PubMed ID: 15284262
[TBL] [Abstract][Full Text] [Related]
16. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
18. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an intermittent schedule of dibromodulcitol in breast cancer.
Tormey DC; Falkson G; Perlin E; Bull J; Blom J; Lippman ME
Cancer Treat Rep; 1976 Nov; 60(11):1593-6. PubMed ID: 1035505
[TBL] [Abstract][Full Text] [Related]
20. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
